Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models

使用基因工程小鼠模型研究前列腺肿瘤发生机制

基本信息

  • 批准号:
    8552875
  • 负责人:
  • 金额:
    $ 65.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages of the parenchyma surrounded by the mesenchyme, stromal fibroblasts, vasculature, and immune cells. It is not known what cell type cancers arise from. We rely on mouse models to prospectively examine early oncogenic events since it is not feasible to study initiation events in human. However, most transgenic mouse models are not cell type specific. We hypothesize that different epithelial subtypes have varied susceptibility for tumor initiation. Since most solid human tumors harbor aberrations in the Rb cell cycle regulatory pathway, we tested the susceptibility of two epithelial subtypes expressing cytokeratin (K) 18 or K19 to the disruption of Rb and its family members p107 and p130 tumor suppression (Rb-TS, collectively) in vivo. We found that tumorigenesis could be initiated in either K18 or K19 cells. However, the susceptibility of epithelial tissues to Rb-TS inactivation was subtype-dependent. For bladder, stomach, lung, and colon epithelium, K19 cells were more susceptible to Rb-TS inactivation, while for thymic epithelium, K18 cells. Moreover, when Rb-TS was inactivated in K19 cells, males had early onset of bladder adenoma compared to females (9 vs 14 months post induction), and only small percentage of animals developed carcinoma/adenocarcinoma, indicating that other genetic event(s) is required for tumor progression. To further assess the susceptibility of prostate epithelium to Rb-TS inactivation, we inactivated Rb-TS in K18 and K19 subtypes in prostate using prostate specific Cre line (Pb-Cre4). To our surprise, mouse prostatic intraepithelial neoplasia (mPIN) lesions were initiated in K19 cells, but not in K18 cells at 2 months of age, indicating that K19 cells are more susceptible to prostate tumorigenesis. Thus, cell subtype tumors are initiated in dictates the histopathological phenotype and onset of tumor development. We are currently in the process of writing up the 1st manuscript and analyzing the mouse prostate phenotype developed in K18 or K19 transgenic mice with Pten deletion. We are also assessing the tumors response to castration in these models. Song Y, Yang C, Pan W, Fathalizadeh A, Lu X, Gilbert D, Wang C, O?Sullivan N, Haines D, Martin P, Van Dyke T. Rb inactivation in epithelial subtypes: Differential susceptibility for tumor initiation. (in preparation)
癌发生在复杂的微环境中,由间充质、基质成纤维细胞、脉管系统和免疫细胞包围的实质的多个不同上皮谱系组成。目前还不清楚癌症是由什么细胞引起的。我们依靠小鼠模型来前瞻性地检查早期致癌事件,因为在人类中研究起始事件是不可行的。然而,大多数转基因小鼠模型不是细胞类型特异性的。我们假设不同的上皮亚型对肿瘤的发生具有不同的易感性。由于大多数人实体肿瘤在Rb细胞周期调控通路中存在畸变,我们在体内测试了表达细胞角蛋白(K)18或K19的两种上皮亚型对Rb及其家族成员p107和p130肿瘤抑制(统称为Rb-TS)的破坏的敏感性。我们发现肿瘤发生可以在K18或K19细胞中启动。然而,上皮组织对Rb-TS失活的敏感性是亚型依赖性的。对于膀胱、胃、肺和结肠上皮,K19细胞更容易受到Rb-TS灭活,而对于胸腺上皮,K18细胞更容易受到Rb-TS灭活。此外,当Rb-TS在K19细胞中失活时,与雌性动物相比,雄性动物的膀胱腺瘤发病较早(诱导后9个月vs 14个月),只有小部分动物发生癌/腺癌,表明肿瘤进展需要其他遗传事件。为了进一步评估前列腺上皮对Rb-TS失活的敏感性,我们使用前列腺特异性Cre线(Pb-Cre 4)失活前列腺中K18和K19亚型中的Rb-TS。令我们惊讶的是,小鼠前列腺上皮内瘤变(mPIN)病变在K19细胞中开始,但在2个月大的K18细胞中没有,表明K19细胞对前列腺肿瘤发生更敏感。因此,细胞亚型肿瘤的起始决定了组织病理学表型和肿瘤发展的开始。我们目前正在撰写第一篇论文,并分析在Pten缺失的K18或K19转基因小鼠中产生的小鼠前列腺表型。我们还评估了这些模型中肿瘤对去势的反应。Song Y,Yang C,Pan W,Fathalizadeh A,Lu X,吉尔伯特D,Wang C,O?刘晓波,刘晓波,货车晓波.上皮细胞亚型中Rb的失活:肿瘤发生的不同易感性。(in(编制)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Terry van Dyke其他文献

Terry van Dyke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Terry van Dyke', 18)}}的其他基金

Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation
Rb TS 抑制使星形胶质细胞去分化,导致星形细胞瘤发生
  • 批准号:
    8763536
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
胶质母细胞瘤中EGFR-Ras信号传导机制的研究
  • 批准号:
    8552936
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
通过系统生物学方法对星形细胞瘤小鼠模型进行通路分析
  • 批准号:
    8938029
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Development of ESiPSC approach for non-germline GEM modeling
开发用于非种系 GEM 建模的 ESiPSC 方法
  • 批准号:
    8938101
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
通过系统生物学方法对星形细胞瘤小鼠模型进行通路分析
  • 批准号:
    8349422
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Development of ESiPSC approach for non-germline GEM modelling
开发用于非种系 GEM 建模的 ESiPSC 方法
  • 批准号:
    8349534
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Development and validation of preclinical mouse model for serous ovarian cancer
浆液性卵巢癌临床前小鼠模型的开发和验证
  • 批准号:
    8349495
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model
基因工程小鼠模型胸腺淋巴瘤发生机制
  • 批准号:
    8349382
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Mechanisms of Early Stage Mammary Tumorigenesis
早期乳腺肿瘤发生机制
  • 批准号:
    8349440
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
Establishing the Preclinical Model for Metastatic Melanoma
建立转移性黑色素瘤的临床前模型
  • 批准号:
    8553206
  • 财政年份:
  • 资助金额:
    $ 65.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了